- Home
- NMRA vs MTLS Comparison
NMRA vs MTLS Comparison
Compare NMRA & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | MTLS |
|---|---|---|
| Founded | 2019 | 1990 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.4M | 340.8M |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NMRA | MTLS |
|---|---|---|
| Price | $2.17 | $5.47 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 154.4K |
| Earning Date | 03-02-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $308,751,613.00 |
| Revenue This Year | N/A | $2.47 |
| Revenue Next Year | N/A | $6.98 |
| P/E Ratio | ★ N/A | $62.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $3.93 |
| 52 Week High | $3.25 | $9.69 |
Technical Indicators
Market Signals| Indicator | NMRA | MTLS |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 42.36 |
| Support Level | $2.06 | $5.55 |
| Resistance Level | $2.57 | $5.80 |
| Average True Range (ATR) | 0.22 | 0.22 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 62.62 | 9.68 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.